The following side effects are given in accordance with WHO classification of the incidence of side effects:
Often - ≥1/10 appointments
often from ≥1 / 100 to <1/10 of assignments
infrequently - from ≥1 / 1000 to <1/100 of the assignments
rarely from ≥1 / 10000 to <1/1000 assignments
very rarely - <1/10000 prescriptions
frequency is not known - according to available data, it is not possible to establish the frequency of occurrence.
Disorders from the gastrointestinal tract
Often: oily discharges from the rectum, the escape of gases with a certain amount of detachable, imperative urges for defecation, steatorrhea.
Often: abdominal pain, fecal incontinence, loose stool, frequent bowel movements.
Postmarketing observations
Violations of the blood and lymphatic system
Frequency not known: decreased prothrombin, increased INR (international normalized attitude). These side effects were observed with the simultaneous use of orlistat and anticoagulants. Disorders from the gastrointestinal tract
Frequency not known: minor bleeding from the rectum, diverticulitis.
Disturbances from the liver and bile ducts
Frequency not known: increased activity of "liver" transaminases, alkaline phosphatase, hepatitis, cholelithiasis.
Disturbances from the skin and subcutaneous tissues
Frequency not known: bullous rash.
Immune system disorders
Frequency not known: skin itching, rash, hives, angioedema, bronchospasm, anaphylaxis.